Optimising the Diagnosis and Management of Treatment Refractory Benign Positioning Vertigo

优化治疗难治性良性定位性眩晕的诊断和管理

• 批准号: nhmrc : 1010017
• 负责人: A/Pr Miriam Welgampola
• 金额: $ 19.1万
• 依托单位: The University of Sydney
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-01-01 至 2014-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/optimising-diagnosis-management-positioning-vertigo/109452
• 关键词: Optimising; Diagnosis; Management; Treatment; Refractory

Benign Positioning Vertigo, the most common and correctable cause of dizziness, is caused by freely floating calcium carbonate crystals in the semicircular canals of the inner ear. Localizing the affected semicircular canal holds the key to effective treatment.A proportion of sufferers will not respond to conventional repositioning treatments due to incorrect diagnoses. This study will explore refractory BPV in detail, develop test methods that accurately localize the affected canal and devise treatments for resistant BPV subtypes.

良性定位性眩晕是最常见和可纠正的头晕原因，是由内耳半规管内自由漂浮的碳酸钙晶体引起的。定位受影响的半规管是有效治疗的关键。由于诊断错误，一部分患者对传统的重新定位治疗没有反应。本研究将详细探讨难治性BPV，开发准确定位受影响管的测试方法，并设计耐药BPV亚型的治疗方法。